Publication | Closed Access

Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

Phase Ii TrialMedicineNeuroblastsNeurologyCancer TreatmentOncologyRadiation OncologyCancer Research